Brian Mueller Insider Trading $BMRN BIOMARIN PHARMACEUTICAL INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Brian Mueller.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Brian Mueller. Brian Mueller is EVP, Chief Financial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and SVP, Acting CFO in BIOMARIN PHARMACEUTICAL INC ($BMRN) and SVP, Corporate Controller in BIOMARIN PHARMACEUTICAL INC ($BMRN) and SVP, Finance and CAO in BIOMARIN PHARMACEUTICAL INC ($BMRN) and VP, Corporate Controller in BIOMARIN PHARMACEUTICAL INC ($BMRN) and in Anthera Pharmaceuticals Inc ($ANTH).

Brian Mueller in BIOMARIN PHARMACEUTICAL INC

Trading Symbol: BMRN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Brian Mueller: EVP, Chief Financial Officer, SVP, Acting CFO, SVP, Finance and CAO, SVP, Corporate Controller, VP, Corporate Controller
Holdings: 31,357 shares
Current Value: $2,787,951
Latest Transaction: May 11 2021
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Brian Mueller in BIOMARIN PHARMACEUTICAL INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ANTH, BMRN

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 11 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Option ExerciseM28.236,709189,3950
May 11 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...SellS79.506,709533,36631,35738.1 K to 31.4 K (-17.62 %)
May 11 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...BuyM28.236,709189,39538,06631.4 K to 38.1 K (+21.40 %)
May 11 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...GrantA62.4134121,28131,35731 K to 31.4 K (+1.10 %)
Apr 02 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...SellS76.305,692434,30031,01636.7 K to 31 K (-15.51 %)
Mar 23 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Payment of ExerciseF78.5251640,51636,70837.2 K to 36.7 K (-1.39 %)
Mar 17 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Option ExerciseA78.3924,8901,951,12724,890
Mar 17 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Payment of ExerciseF77.2158244,93637,22437.8 K to 37.2 K (-1.54 %)
Mar 17 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Payment of ExerciseF78.3999477,92037,80638.8 K to 37.8 K (-2.56 %)
Mar 17 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...GrantA0.0010,110038,80028.7 K to 38.8 K (+35.24 %)
Feb 04 2021BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Payment of ExerciseF82.821,07188,70028,67329.7 K to 28.7 K (-3.60 %)
Jun 30 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Option ExerciseA122.1813,2301,616,44113,230
Jun 30 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...GrantA0.004,640029,74425.1 K to 29.7 K (+18.48 %)
Jun 30 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...GrantA62.5932320,21525,10424.8 K to 25.1 K (+1.30 %)
Jun 30 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...Option ExerciseA122.1813,2301,616,44113,230
Jun 30 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...GrantA0.004,640029,74425.1 K to 29.7 K (+18.48 %)
Jun 30 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianEVP, Chief Financia ...GrantA62.5932320,21525,10424.8 K to 25.1 K (+1.30 %)
Mar 24 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Acting CFOPayment of ExerciseF73.0541430,24324,78125.2 K to 24.8 K (-1.64 %)
Mar 17 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Acting CFOOption ExerciseA73.829,600708,6729,600
Mar 17 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Acting CFOGrantA0.006,730025,19518.5 K to 25.2 K (+36.45 %)
Mar 17 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Acting CFOPayment of ExerciseF84.501,303110,10418,46519.8 K to 18.5 K (-6.59 %)
Feb 04 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Acting CFOGrantA0.005,800019,76814 K to 19.8 K (+41.52 %)
Feb 04 2020BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Acting CFOGrantA62.23956013,96814 K to 14 K (+0.06 %)
Jun 07 2019BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Finance and CA ...GrantA68.7829920,56613,95913.7 K to 14 K (+2.19 %)
Apr 09 2019BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS94.002,953277,58213,66016.6 K to 13.7 K (-17.78 %)
Mar 26 2019BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF88.0541536,54116,61317 K to 16.6 K (-2.44 %)
Mar 19 2019BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Option ExerciseA94.539,650912,2159,650
Mar 19 2019BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...GrantA0.005,780017,02811.2 K to 17 K (+51.39 %)
Mar 19 2019BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF94.531,149108,61511,24812.4 K to 11.2 K (-9.27 %)
Dec 20 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...GrantA68.78221,51312,39712.4 K to 12.4 K (+0.18 %)
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Option ExerciseM28.232,49170,3211,718
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Option ExerciseM28.232,49170,3211,718
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS99.502,491247,85512,37514.9 K to 12.4 K (-16.76 %)
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS99.502,491247,85512,37514.9 K to 12.4 K (-16.76 %)
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...BuyM28.232,49170,32114,86612.4 K to 14.9 K (+20.13 %)
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...BuyM28.232,49170,32114,86612.4 K to 14.9 K (+20.13 %)
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS99.5065465,07312,37513 K to 12.4 K (-5.02 %)
Jun 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS99.5065465,07312,37513 K to 12.4 K (-5.02 %)
Jun 18 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS94.502,021190,98513,02915.1 K to 13 K (-13.43 %)
Jun 06 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF92.0734631,85615,05015.4 K to 15.1 K (-2.25 %)
May 14 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS89.502,450219,27515,39617.8 K to 15.4 K (-13.73 %)
May 14 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...GrantA68.7828719,74017,84617.6 K to 17.8 K (+1.63 %)
Mar 26 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF81.3641433,68317,55918 K to 17.6 K (-2.30 %)
Mar 20 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Option ExerciseA83.579,120762,1589,120
Mar 20 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...GrantA0.005,710017,97312.3 K to 18 K (+46.56 %)
Mar 20 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF84.1034629,09912,26312.6 K to 12.3 K (-2.74 %)
Mar 20 2018BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF83.5730925,82312,60912.9 K to 12.6 K (-2.39 %)
Jun 23 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Option ExerciseM21.512,67157,4530
Jun 23 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS100.002,671267,10012,88515.6 K to 12.9 K (-17.17 %)
Jun 23 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...BuyM21.512,67157,45315,55612.9 K to 15.6 K (+20.73 %)
Jun 06 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF90.7237634,11112,88513.3 K to 12.9 K (-2.84 %)
May 17 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF91.5020718,94113,26113.5 K to 13.3 K (-1.54 %)
May 10 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Option ExerciseM21.512,60055,9262,671
May 10 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS93.172,600242,24213,46816.1 K to 13.5 K (-16.18 %)
May 10 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...BuyM21.512,60055,92616,06813.5 K to 16.1 K (+19.31 %)
May 10 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...SellS91.174,882445,09213,46818.4 K to 13.5 K (-26.60 %)
May 10 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...GrantA70.3027018,98218,35018.1 K to 18.4 K (+1.49 %)
Mar 24 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Option ExerciseA87.427,740676,6317,740
Mar 24 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...GrantA0.004,790018,08013.3 K to 18.1 K (+36.04 %)
Mar 17 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF90.9637634,20113,29013.7 K to 13.3 K (-2.75 %)
Mar 17 2017BMRNBIOMARIN PHARMACEU ...Mueller BrianSVP, Corporate Cont ...Payment of ExerciseF92.5033631,08013,66614 K to 13.7 K (-2.40 %)
Aug 03 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...SellS100.0028728,70014,26014.5 K to 14.3 K (-1.97 %)
Jun 07 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF90.0037633,84014,54714.9 K to 14.5 K (-2.52 %)
May 17 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF82.7120717,12114,92315.1 K to 14.9 K (-1.37 %)
May 10 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF80.8044435,87515,13015.6 K to 15.1 K (-2.85 %)
May 10 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...GrantA51.2632716,76315,57415.2 K to 15.6 K (+2.14 %)
Mar 17 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Option ExerciseA83.437,000584,0107,000
Mar 17 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF80.3437630,20815,24715.6 K to 15.2 K (-2.41 %)
Mar 17 2016BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...GrantA0.003,570015,62312.1 K to 15.6 K (+29.62 %)
Jun 08 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF120.4652262,88011,92612.4 K to 11.9 K (-4.19 %)
Jun 03 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF125.5730838,67612,44812.8 K to 12.4 K (-2.41 %)
May 19 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF122.7820725,41512,75613 K to 12.8 K (-1.60 %)
May 12 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Payment of ExerciseF121.6644454,01712,96313.4 K to 13 K (-3.31 %)
May 12 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...GrantA51.2660731,11713,40712.8 K to 13.4 K (+4.74 %)
Mar 17 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Option ExerciseA124.379,0001,119,3309,000
Mar 17 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...GrantA0.004,000012,8008.8 K to 12.8 K (+45.45 %)
Mar 05 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Option ExerciseM28.237,000197,6107,491
Mar 05 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...SellS109.467,000766,2108,80015.8 K to 8.8 K (-44.30 %)
Mar 05 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...BuyM28.237,000197,61015,8008.8 K to 15.8 K (+79.55 %)
Mar 05 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...Option ExerciseA63.1010,000631,00010,000
Mar 05 2015BMRNBIOMARIN PHARMACEU ...Mueller BrianVP, Corporate Contr ...GrantA0.004,00008,8004.8 K to 8.8 K (+83.33 %)

Page:   1

Contact us | Follow us on Twitter